Albireo Pharma Inc (ALBO):企業の財務・戦略的SWOT分析

◆英語タイトル:Albireo Pharma Inc (ALBO) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0162
◆発行会社(調査会社):GlobalData
◆発行日:2019年11月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Albireo Pharma Inc (ALBO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Albireo Pharma Inc (Albireo), formerly Biodel Inc, focuses on the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and other liver and gastrointestinal (GI) disorders and diseases. The company’s lead product candidate, A4250 is a novel, minimally absorbed, orally administered ileal sodium dependent bile acid transporter (IBAT) inhibitor. It is investigating its lead candidate, A4250 is being developed for the treatment of progressive familial intrahepatic cholestasis (PFIC), a rare, life-threatening genetic disorder that affects young children and as a potential treatment for other orphan pediatric liver diseases. Albireo is headquartered in Boston, Massachusetts, the US.

Albireo Pharma Inc Key Recent Developments

Nov 06,2019: Albireo reports third quarter 2019 financial results and provides business update
Nov 04,2019: Albireo appoints Michelle Graham as Chief Human Resources Officer
Aug 08,2019: Albireo reports second quarter 2019 financial results
May 09,2019: Albireo reports first quarter 2019 financial results
Mar 21,2019: Albireo expands executive leadership team with appointment of Pamela Stephenson as Chief Commercial Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Albireo Pharma Inc – Key Facts
Albireo Pharma Inc – Key Employees
Albireo Pharma Inc – Key Employee Biographies
Albireo Pharma Inc – Major Products and Services
Albireo Pharma Inc – History
Albireo Pharma Inc – Company Statement
Albireo Pharma Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Albireo Pharma Inc – Business Description
R&D Overview
Albireo Pharma Inc – Corporate Strategy
Albireo Pharma Inc – SWOT Analysis
SWOT Analysis – Overview
Albireo Pharma Inc – Strengths
Albireo Pharma Inc – Weaknesses
Albireo Pharma Inc – Opportunities
Albireo Pharma Inc – Threats
Albireo Pharma Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Albireo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Albireo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Albireo Pharma Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 06, 2019: Albireo reports third quarter 2019 financial results and provides business update
Nov 04, 2019: Albireo appoints Michelle Graham as Chief Human Resources Officer
Aug 08, 2019: Albireo reports second quarter 2019 financial results
May 09, 2019: Albireo reports first quarter 2019 financial results
Mar 21, 2019: Albireo expands executive leadership team with appointment of Pamela Stephenson as Chief Commercial Officer
Mar 07, 2019: Albireo reports year-end 2018 financial results and provides pipeline update
Feb 28, 2019: Albireo recognizes rare disease day and highlights urgent need to support families affected by progressive familial intrahepatic cholestasis (pfic)
Nov 13, 2018: Albireo reports third quarter 2018 financial results
Oct 10, 2018: Albireo appoints Simon Harford as chief financial officer and treasurer
Aug 07, 2018: Albireo reports second quarter 2018 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Albireo Pharma Inc, Key Facts
Albireo Pharma Inc, Key Employees
Albireo Pharma Inc, Key Employee Biographies
Albireo Pharma Inc, Major Products and Services
Albireo Pharma Inc, History
Albireo Pharma Inc, Other Locations
Albireo Pharma Inc, Subsidiaries
Albireo Pharma Inc, Key Competitors
Albireo Pharma Inc, Ratios based on current share price
Albireo Pharma Inc, Annual Ratios
Albireo Pharma Inc, Annual Ratios (Cont...1)
Albireo Pharma Inc, Interim Ratios
Albireo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Albireo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Albireo Pharma Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Albireo Pharma Inc, Performance Chart (2014 - 2018)
Albireo Pharma Inc, Ratio Charts
Albireo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Albireo Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Albireo Pharma Inc (ALBO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • United Microelectronics Corporation (2303):企業の財務・戦略的SWOT分析
    United Microelectronics Corporation (2303) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Condor Petroleum Inc (CPI):石油・ガス:M&Aディール及び事業提携情報
    Summary Condor Petroleum Inc. (Condor) is an independent upstream oil and gas company. The company through its subsidiaries, acquires, explores, produces and markets oil and gas. It has operational presence in Kazakhstan and Turkey. The company operates on the Pre-Caspian basin, a prolific region th …
  • Cellect Biotechnology Ltd (APOP):医療機器:M&Aディール及び事業提携情報
    Summary Cellect Biotechnology Ltd (Cellect Biotechnology) formerly Cellect Biomed Ltd is a clinical stage biotechnology company which develops stem cell selection technologies for the production of stem cells based products in the field of regenerative medicine. The company’s technology platform is …
  • Can-Pack S.A.:企業の戦略・SWOT・財務情報
    Can-Pack S.A. - Strategy, SWOT and Corporate Finance Report Summary Can-Pack S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Royal Boskalis Westminster NV:企業のM&A・事業提携・投資動向
    Royal Boskalis Westminster NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Royal Boskalis Westminster NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Physiomics Plc (PYC):企業の財務・戦略的SWOT分析
    Physiomics Plc (PYC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • CNX Resources Corp (CNX):石油・ガス:M&Aディール及び事業提携情報
    Summary CNX Resources Corporation (CNX Resources), formerly CONSOL Energy Inc., is an independent oil and natural gas company. It carries out the exploration, development, production, gathering, processing and acquisition of natural gas properties in the Appalachian Basin. The company has interests …
  • Companhia Energetica de Minas Gerais SA (CMIG4):電力:M&Aディール及び事業提携情報
    Summary Companhia Energetica de Minas Gerais SA (CEMIG) is an integrated energy utility. Through its subsidiaries and jointly-controlled investees, the company has presence in the electricity vertical. The company produces power from biomass, wind, solar, hydro, fossil, and nuclear sources; and proc …
  • SIFCO Industries, Inc.:戦略・SWOT・企業財務分析
    SIFCO Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary SIFCO Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • CiToxLAB Group:製薬・医療:M&Aディール及び事業提携情報
    Summary CiToxLab Group (CiToxLab) is a contract research organization that provides preclinical and specialty services. The company provides toxicology and safety pharmacology, biomarkers, pharmacokinetics, immunology services, surgical models and medical device implantation, animal efficacy models, …
  • MORRE-TEC Industries, Inc.:企業の戦略・SWOT・財務情報
    MORRE-TEC Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary MORRE-TEC Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • General Motors Co (GM):企業の財務・戦略的SWOT分析
    General Motors Co (GM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Janssen Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Janssen Pharmaceuticals Inc (Janssen), a subsidiary of Johnson & Johnson is a healthcare products provider that offers various medicines. The company offers medicines for an array of health conditions in therapeutic areas of attention deficit hyperactivity disorder, general medicine, mental …
  • Nippon Seiro Co., Ltd. (5010):企業の財務・戦略的SWOT分析
    Nippon Seiro Co., Ltd. (5010) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Covalon Technologies Ltd (COV):企業の財務・戦略的SWOT分析
    Summary Covalon Technologies Ltd (Covalon) is a researcher, developer and commercializer of medical products and healthcare technologies. The company offers advanced wound care, infection prevention and perioperative care products. Its wound care products include collagen matrix dressing, collagen m …
  • Opiant Pharmaceuticals Inc (OPNT):医療機器:M&Aディール及び事業提携情報
    Summary Opiant Pharmaceuticals Inc (Opiant), formerly, Lightlake Therapeutics Inc is a specialty pharmaceutical company that develops pharmacological treatments for substance use, addiction and eating disorders. It focuses on developing treatments to reverse opioid overdoses, for overweight and obes …
  • Saudi Industrial Export Company (4140):企業の財務・戦略的SWOT分析
    Summary Saudi Industrial Export Company (SIEC) is a chemical providing company that imports, exports and selss specialty chemicals, fertilizers, industrial materials and commodities. The company's fertilizers include diammonium phosphate, sulphur, urea, triple super phosphate, granular triple super …
  • The Boeing Company:企業の戦略・SWOT・財務情報
    The Boeing Company - Strategy, SWOT and Corporate Finance Report Summary The Boeing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • New Zealand Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary New Zealand Pharmaceuticals Ltd (NZP) a subsidiary of Archer Capital, manufactures and supplies pharmaceutical intermediates and diagnostic products for pharmaceutical and microbiological media companies. It also offers biochemicals and natural extracts for health, cosmetic, biotechnology, f …
  • Illumina Inc (ILMN):企業の財務・戦略的SWOT分析
    Illumina Inc (ILMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆